James E. Flynn

Holdings History for ARS Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (SPRY)

Symbol: SPRY on Nasdaq
Investment type: Equity / Common Stock, par value $0.0001 per share
Latest Disclosed Shares Owned: 7,610,217 shares
Security Ownership %: 7.8%

Deerfield Management Company, L.P. ownership in ARS Pharmaceuticals, Inc. Common Stock, par value $0.0001 per share (SPRY)

01 Aug 2025 - Deerfield Management Company, L.P. has filed an SCHEDULE 13D/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 7,610,217 shares of ARS Pharmaceuticals, Inc. Common Stock, par value $0.0001 per share (SPRY). This represents 7.8% ownership of the company. In their previous filing dated 22 Jul 2025, James E. Flynn had reported owning 8,633,537 shares, indicating a decrease of +12%. .

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
Deerfield Management Company, L.P.	7.8%	-12%	$134,624,739	7,610,217	-1,023,320	-12%	$17.69	13D/A	30 Jul 2025	01 Aug 2025, 18:06
Deerfield Management Company, L.P.	8.8%	-11%	$150,656,084	8,633,537	-1,090,971	-11%	$17.45	13D/A	18 Jul 2025	22 Jul 2025, 19:38
Deerfield Management Company, L.P.	9.9%	-7.5%	$140,032,915	9,724,508	-790,149	-7.5%	$14.40	13D/A	02 Jul 2025	02 Jul 2025, 08:24
Deerfield Management Company, L.P.	11%		$153,934,578	10,514,657			$14.64	13D/A	20 Mar 2025	24 Mar 2025, 19:57